Cullinan Therapeutics, Inc. (CGEM) Return On Assets % [USD] 2021 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cullinan Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2021 to 2024.
  • Cullinan Therapeutics, Inc. Return On Assets for the quarter ending March 31, 2024 was -27.1 %, a 345% decline year-over-year.
  • Cullinan Therapeutics, Inc. annual Return On Assets for 2023 was -30.4 %, a 256% decline from 2022.
  • Cullinan Therapeutics, Inc. annual Return On Assets for 2022 was 19.5 %.
Return On Assets, Quarterly (% [USD])
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -27.1 -38.2 -345% Jan 1, 2024 Mar 31, 2024
Q4 2023 -30.4 -49.9 -256% Oct 1, 2023 Dec 31, 2023
Q3 2023 -29.8 -49.4 -253% Jul 1, 2023 Sep 30, 2023
Q2 2023 -25.6 -48.2 -213% Apr 1, 2023 Jun 30, 2023
Q1 2023 11.1 +28.4 Jan 1, 2023 Mar 31, 2023
Q4 2022 19.5 +33.8 Oct 1, 2022 Dec 31, 2022
Q3 2022 19.5 +34.8 Jul 1, 2022 Sep 30, 2022
Q2 2022 22.6 Apr 1, 2022 Jun 30, 2022
Q1 2022 -17.3 Jan 1, 2022 Mar 31, 2022
Q4 2021 -14.3 Oct 1, 2021 Dec 31, 2021
Q3 2021 -15.2 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.